Aviv Amirav, School of Chemistry, Tel Aviv University and Director – Aviv Analytical
Drugs are typically analyzed by LC-MS. When active pharmaceutical ingredients (API) are analyzed for the presence of impurities, the general requirements are that every impurity found should be at concentration below 0.1% of the API or it must be either cleaned or identified and toxicologically characterized which is a time consuming and expensive procedure. However, the ionization yields of Electrospray and/or APCI in LC-MS are highly non-uniform and compound dependent, and as a result when an impurity is found in a given LC-MS mass chromatogram its actual concentration is not known. Consequently, regardless of its actual concentration that can be well below 0.1% every impurity that is found must be isolated, fully identified, synthesized (or obtained) and serve for the provision of a calibration curve in order to measure the actual concentration of that small impurity peak. In addition, several types of impurities such as non-polar compounds are not properly ionized and are not detected by LC-MS. Thus, clearly drug impurity analysis represents an unmet analytical challenge.
Alternatively, GC-MS with its standard electron ionization (EI) can be used and has, for volatile compounds, approximately uniform, semi-quantitative ionization yield. However, GC-MS with standard EI is compatible only with a limited range of thermally stable drugs and it provides useful molecular ions only for a portion of the analyzed compounds. Furthermore, ion source degradation and peak tailing severely erode the standard EI response uniformity for semi-volatile compounds.
We used the
Aviv Analytical 5975-SMB GC-MS with Cold EI for the analysis of drug impurities. Cold EI is the electron ionization of cold molecules in supersonic molecular beams (SMB). The technology of GC-MS with Cold EI is reviewed by A. Amirav, A. Gordin, M. Poliak, and A. B. Fialkov, J. Mass Spectrom., 43, 141-163. (2008). The later is available upon request.
GC-MS with Cold EI as implemented with the Aviv Analytical 5975-SMB uniquely extends the range of drugs that are amenable for GC-MS analysis, including thermally labile drugs that are not compatible with standard GC-MS analysis. Furthermore, it is characterized by having uniform response to all compounds due to its contact-free fly-through ion source that eliminates any ion source peak tailing or losses. In addition, it provides trustworthy enhanced molecular ions that can be converted with the
Tal-Aviv Molecule Identifier software into elemental formulae. Thus, the high sensitivity and uniform response of Cold EI uniquely enables the detection, identification and quantitation of low level impurities in drugs without lengthy calibration procedures.
In order to evaluated the above attributes of the 5975-SMB we analyzed impurities in two Active Pharmaceutical Ingredient (API) samples (powder form) of Haloperidol and Ramelteon (Structures are given below).
Keep reading to find our how the Aviv Analytical 5975-SMB GC-MS with Cold EI uniquely enables quantitative drug impurities analysis and helps in their identification.